Promising drug against non-alcoholic steatohepatitis, a severe type of liver disease

by Fundació Bosch i Gimpera

Nonalcoholic steatohepatitis (NASH) affects 2 to 5 percent of the world’s population. It is the most severe form of fatty liver disease, which can lead to cirrhosis, among other complications, and i...

Read more

Researchers discover a protein that protects against fatty liver, the most common hepatic disease in Western countries

by IRB Barcelona - Instituto de Investigación Biomédica

It is a disease of the liver caused by excessive fat deposits in liver cells. It is now the most prevalent chronic liver disease in industrialised countries and is a major public health concern becaus...

Read more

The stabilization of new lipid mediators derived from omega-3 fatty acids reduces the liver inflammation caused by obesity

by Fundació Clínic per a la Recerca Biomèdica

Inhibitors of sEH are suggested as a promising therapeutic strategy to prevent and counteract the consequences of obesity. Based on the significant results obtained in this work new studies will be la...

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

Una nueva vacuna experimental es capaz d...

by Agencia Sinc

Mejorar el diseño de las vacunas contra el cáncer es uno de los gran...

Photos Stream